Lucid Diagnostics Inc.
NASDAQ: LUCD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Lishan Aklog
- Employees
- 72
- Headquarters
- New York City, United States
- IPO year
- 2021
- Market cap
- $104.4M
- Website
- https://www.luciddx.com
Loading LUCD…
Loading profile data…Frequently asked questions about LUCD
What does Lucid Diagnostics Inc. (LUCD) do?
Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal condit...
Where does LUCD trade?
Lucid Diagnostics Inc. (LUCD) trades on the NASDAQ Global Market.
What sector is LUCD in?
Lucid Diagnostics Inc. (LUCD) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Lucid Diagnostics Inc.?
Lishan Aklog is the chief executive officer of Lucid Diagnostics Inc. (LUCD).
Where is Lucid Diagnostics Inc. headquartered?
Lucid Diagnostics Inc. is headquartered in United States.
Does LUCD pay a dividend?
Lucid Diagnostics Inc. (LUCD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LUCD go public?
Lucid Diagnostics Inc. (LUCD) completed its initial public offering in 2021.